Clorox (CLX) to Release Earnings on Thursday

Clorox (NYSE:CLX - Get Free Report) is anticipated to announce its Q4 2025 earnings results after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $2.25 per share and revenue of $1.94 billion for the quarter. Clorox has set its FY 2025 guidance at 6.950-7.350 EPS.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The firm's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.71 EPS. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Price Performance

CLX stock traded down $0.62 during mid-day trading on Friday, hitting $130.80. The company had a trading volume of 1,287,038 shares, compared to its average volume of 1,776,629. The company has a market capitalization of $16.12 billion, a price-to-earnings ratio of 23.48, a P/E/G ratio of 3.44 and a beta of 0.51. Clorox has a 12-month low of $117.35 and a 12-month high of $171.37. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The company has a 50-day moving average price of $126.77 and a 200 day moving average price of $140.15.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director owned 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.57% of the company's stock.

Institutional Investors Weigh In On Clorox

A hedge fund recently raised its stake in Clorox stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 4.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,380 shares of the company's stock after acquiring an additional 514 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Clorox were worth $1,970,000 as of its most recent filing with the Securities & Exchange Commission. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Barclays decreased their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Citigroup restated a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. UBS Group decreased their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Finally, Morgan Stanley decreased their target price on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $144.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.